Eastwood Bio-Medical Canada (TSXV:EBM) Other Current Liabilities: C$0.00 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:EBM Eastwood Bio-Medical Canada Inc TSXV:EBM
25 GF Score
Price C$1.91
GF Value C$0.52
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Eastwood Bio-Medical Canada Other Current Liabilities?

Eastwood Bio-Medical Canada TSXV:EBM +4.32% 25 Other Current Liabilities is C$0.00 Mil as of Apr. 2026. GuruFocus rates TSXV:EBM with a GF Score™ of 25/100 and a GF Value™ of C$0.52 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Eastwood Bio-Medical Canada's other current liabilities for the quarter that ended in Apr. 2026 was C$0.00 Mil.

Eastwood Bio-Medical Canada's quarterly other current liabilities declined from Oct. 2025 (C$0.00 Mil) to Jan. 2026 (C$0.00 Mil) but then from Jan. 2026 (C$0.00 Mil) to Apr. 2026 (C$0.00 Mil).

Eastwood Bio-Medical Canada's annual other current liabilities declined from Oct. 2023 (C$0.00 Mil) to Oct. 2024 (C$-0.00 Mil) but then increased from Oct. 2024 (C$-0.00 Mil) to Oct. 2025 (C$0.00 Mil).

Eastwood Bio-Medical Canada Other Current Liabilities Related Terms

Eastwood Bio-Medical Canada Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Eastwood Bio-Medical Canada's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eastwood Bio-Medical Canada Other Current Liabilities Chart

Eastwood Bio-Medical Canada Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 0.00 -0.00 0.00

Eastwood Bio-Medical Canada Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 0.00
TSXV:EBM
25GF Score
Eastwood Bio-Medical Canada Inc TSXV:EBM
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eastwood Bio-Medical Canada Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of C$0.00 Mil mean?
Eastwood Bio-Medical Canada (TSXV:EBM) has a Other Current Liabilities of C$0.00 Mil as of Apr. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Eastwood Bio-Medical Canada.
Is Eastwood Bio-Medical Canada's Other Current Liabilities too high?
Eastwood Bio-Medical Canada's current Other Current Liabilities is C$0.00 Mil. Overall, Eastwood Bio-Medical Canada has a GF Score™ of 25/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Eastwood Bio-Medical Canada's Other Current Liabilities compare to VRTX and REGN?
Eastwood Bio-Medical Canada's Other Current Liabilities of C$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Eastwood Bio-Medical Canada. Eastwood Bio-Medical Canada's current Other Current Liabilities is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eastwood Bio-Medical Canada stock overvalued right now?
Based on GuruFocus' analysis, Eastwood Bio-Medical Canada (TSXV:EBM) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.52, compared to a current price of C$1.91 — trading 267.3% above its estimated fair value. The current Other Current Liabilities is C$0.00 Mil. Eastwood Bio-Medical Canada's overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Eastwood Bio-Medical Canada (TSXV:EBM), the current Other Current Liabilities is C$0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eastwood Bio-Medical Canada (TSXV:EBM) Overvalued in 2026?

Based on GuruFocus' analysis, Eastwood Bio-Medical Canada stock appears to be overvalued. The current stock price of C$1.91 is trading 267.3% above its estimated GF Value™ of C$0.52. GuruFocus considers Eastwood Bio-Medical Canada to be Significantly Overvalued.

Key valuation signals for TSXV:EBM:

  • Other Current Liabilities: C$0.00 Mil
  • GF Value™: C$0.52 vs. price of C$1.91 (267.3% above fair value)
  • GF Score™: 25/100 with 5 warning signs

No single metric tells the full story. See the TSXV:EBM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eastwood Bio-Medical Canada Business Description

Address 4871 Shell Road, Suite 1130, Richmond, BC, CAN, V6X 3Z6
Eastwood Bio-Medical Canada Inc is a Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The company is engaged in natural health supplement distribution company. It has its geographic presence in U.S., Canada and Asia. The company generates maximum revenue from Asia.
25GF Score

Get the complete analysis for TSXV:EBM

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.91
Price
C$0.52
GF Value